Advertisement

Measurement of mucociliary clearance in the patients with multiple sclerosis

  • Ender SahinEmail author
  • Mehmet Hamamcı
  • Yunus Kantekin
Rhinology

Abstract

Objectives

The aim of the present study was to measure nasal mucociliary clearance (NMC) time in the patients with MS and to compare the findings with healthy population.

Methods

Totally 97 individuals including 47 patients with relapsing–remitting multiple sclerosis and 50 healthy volunteers were enrolled into the study. Saccharin clearance test was performed on both groups and NMC time was measured. Data analysis was performed by SPSS version 24.0 statistics program (SPSS Inc., Chicago, Illinois, USA). Statistical tests were interpreted at p < 0.05 significance level.

Results

The NMC time averages in MS patients and healthy control group were 12.43 ± 4.05 min and 8.14 ± 2.87 min, respectively; the difference between the groups was significant (p < 0.001). There was a statistically strong association between NMC time values and Expanded Disability Status Scale (EDSS) values in MS patients (r = 0.817, p < 0.001).

Conclusion

We found nasal mucociliary transport time longer in MS patients than healthy population in the present study. To the best of our knowledge, there is not any study conducted about this topic in the literature. We believe that our findings would shed a light on further studies.

Keywords

Infection Disability Nasal Mucociliary clearance 

Notes

Funding

None.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This study was approved by the Institutional Review Board of the Yozgat Bozok University.

Informed consent

Written informed consent was obtained from the patients.

References

  1. 1.
    Compston A, Coles A (2008) Multiplesclerosis. Lancet 372(9648):1502–1517.  https://doi.org/10.1016/S0140-6736(08)61620-7 CrossRefPubMedGoogle Scholar
  2. 2.
    Thompson AJ, Baranzini SE, Geurts J et al (2018) Multiple sclerosis. Lancet 391:1622–1636.  https://doi.org/10.1016/S0140-6736(18)30481-1 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Wijnands JM, Kingwell E, Zhu F, Zhao Y, Fisk JD, Evans C, Marrie RA, Tremlett H (2017) Infection related health care utilization among people with and without multiple sclerosis. Mult Scler 23(11):1506–1516.  https://doi.org/10.1177/1352458516681198 CrossRefPubMedGoogle Scholar
  4. 4.
    Gudis DA, Cohen NA (2010) Ciliadysfunction. Otolaryngol Clin N Am 43:461–472.  https://doi.org/10.1016/j.otc.2010.02.007 CrossRefGoogle Scholar
  5. 5.
    Andersen I, Camner P, Jensen PL, Philipson K, Proctor DF (1974) A comparison of nasal and tracheobronchial clearance. Arch Environ Health 29(5):290–293CrossRefGoogle Scholar
  6. 6.
    Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162–173.  https://doi.org/10.1016/s1474-4422(17)30470-2 CrossRefPubMedGoogle Scholar
  7. 7.
    Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1446.  https://doi.org/10.1212/wnl.33.11.1444 CrossRefPubMedGoogle Scholar
  8. 8.
    Akcan FA, Dündar Y, Akcan HB, Uluat A, Cebeci D, Ünlü İ (2019) Evaluation of nasal mucociliary clearance time in patients with Vitamin-D deficiency. Eur Arch Otorhinolaryngol 276(4):1075–1080.  https://doi.org/10.1007/s00405-019-05286-y CrossRefPubMedGoogle Scholar
  9. 9.
    Montgomery S, Hillert J, Bahmanyar S (2013) Hospital admission due to infections in multiple sclerosis patients. Eur J Neurol 20:1153–1160.  https://doi.org/10.1111/ene.12130 CrossRefPubMedGoogle Scholar
  10. 10.
    Nelson RE, Xie Y, DuVall SL, Butler J, Kamauu AW, Knippenberg K, Schuerch M, Foskett N, LaFleur J (2015) Multiple sclerosis and risk of infection-related hospitalization and death in US veterans. Int J MS Care 17:221–230.  https://doi.org/10.1111/ene.12130 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Sibley WA, Foley JM (1965) Infection and immunization in multiple sclerosis. Ann N Y Acad Sci 122:457–466CrossRefGoogle Scholar
  12. 12.
    Steelman AJ (2015) Infection as an environmental trigger of multiple sclerosis disease exacerbation. Front Immunol 19(6):520.  https://doi.org/10.3389/fimmu.2015.00520 CrossRefGoogle Scholar
  13. 13.
    Marrodan M, Alessandro L, Farez MF, Correale J (2019) The role of infections in multiplesclerosis. Mult Scler 25(7):891–901.  https://doi.org/10.1177/1352458518823940 CrossRefPubMedGoogle Scholar
  14. 14.
    Andersen O, Lygner PE, Bergstrom T, Andersson M, Vahlne A (1993) Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 240(7):417–422.  https://doi.org/10.1007/BF00867354 CrossRefPubMedGoogle Scholar
  15. 15.
    Kriesel JD, White A, Hayden FG, Spruance SL, Petajan J (2004) Multiple sclerosis attacks are associated with picornavirus infections. Mult Scler 10(2):145–148.  https://doi.org/10.1191/1352458504ms1005oa CrossRefPubMedGoogle Scholar
  16. 16.
    Correale J, Fiol M, Gilmore W (2006) The risk of relapses in multiple sclerosis during systemic infections. Neurology 67(4):652–659.  https://doi.org/10.1212/01.wnl.0000233834.09743.3b CrossRefPubMedGoogle Scholar
  17. 17.
    Edwards S, Zvartau M, Clarke H, Irving W, Blumhardt LD (1998) Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatry 64(6):736–741.  https://doi.org/10.1136/jnnp.64.6.736 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Winkelmann A, Loebermann M, Reisinger EC, Zettl UK (2014) Multiple sclerosis treatment and infectious issues: update 2013. Clin Exp Neuroimmunol 175:425–438.  https://doi.org/10.1111/cei.12226 CrossRefGoogle Scholar
  19. 19.
    Stevens WW, Lee RJ, Schleimer RP, Cohen NA (2015) Chronic rhinosinusitis pathogenesis. J Allergy Clin Immunol 136:1442–1453.  https://doi.org/10.1016/j.jaci.2015.10.009 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Gudis D, Zhao KQ, Cohen NA (2012) Acquired cilia dysfunction in chronic rhinosinusitis. Am J Rhinol Allergy 26:1–6.  https://doi.org/10.1016/j.jaci.2015.10.009 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Sun SS, Hsieh JF, Tsai SC, Ho YJ, Kao CH (2000) The role of rhinoscintigraphy in the evaluation of nasal mucociliary clearance function in patients with sinusitis. Nucl Med Commun 21:1029–1032CrossRefGoogle Scholar
  22. 22.
    Sadeghi J, Alizadeh N, Ahangar Oskouei M, Laghusi D, Savadi Oskouei D, Nikanfar M, Seyyed Mousavi MN (2019) Frequency of superantigen encoding genes of Staphylococcus aureus isolates collected from multiple sclerosis (MS) patients and nasal carriers. Microb Pathog 127:316–319.  https://doi.org/10.1016/j.micpath.2018.12.010 CrossRefPubMedGoogle Scholar
  23. 23.
    Guan WJ, Peng Y, Zi XX, Tan KS, He TT, Zhong NS, Wang Y (2018) Motile ciliary disorders in chronic airway inflammatory diseases: critical target for interventions. Curr Allergy Asthma Rep 18(9):48.  https://doi.org/10.1007/s11882-018-0802-x CrossRefPubMedGoogle Scholar
  24. 24.
    Lovato A, Staffieri C, Ottaviano G, Cappellesso R, Giacomelli L, Bartolucci GB, Scapellato ML, Marioni G (2016) Woodworkers and the inflammatory effects of softwood/hardwood dust: evidence from nasal cytology. Eur Arch Otorhinolaryngol 273:3195–3200.  https://doi.org/10.1007/s00405-016-3989-2 CrossRefPubMedGoogle Scholar
  25. 25.
    Staffieri C, Lovato A, Aielli F, Bortoletto M, Giacomelli L, Carrieri M, Romeo S, Boscolo-Rizzo P, Da Mosto MC, Bartolucci GB, Marioni G, Scapellato ML (2015) Investigating nasal cytology as a potential tool for diagnosing occupational rhinitis in woodworkers. Int Forum Allergy Rhinol 5:814–819.  https://doi.org/10.1002/alr.21562 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Otolaryngology, Faculty of MedicineBozok UniversityYozgatTurkey
  2. 2.Department of Neurology, Faculty of MedicineBozok UniversityYozgatTurkey

Personalised recommendations